PAVmed (PAVM) director granted 150,000 restricted shares

PAVmed Inc. director Ronald M. Sparks reported a grant of 150,000 restricted shares on 09/30/2025.

Rhea-AI Filing Summary

PAVmed Inc. director Ronald M. Sparks reported a grant of 150,000 restricted shares on 09/30/2025. The shares were issued at a price of $0 and carry a single vesting date of May 20, 2028. After the grant, the reporting person beneficially owns 215,000 shares in total. The restricted stock is subject to forfeiture if the required service period is not completed.

Positive

• 150,000 restricted shares granted to a director, indicating alignment of management incentives with shareholders
• Beneficial ownership increased to 215,000 shares, strengthening the director's stake in the company

Negative

• Restricted shares are forfeitable if the requisite service period is not completed
• Shares issued at $0, reflecting no immediate cash outlay and potential dilution (grant-based)

Insights

Corporate Governance Expert

Director received restricted stock that vests in 2028, increasing beneficial ownership to 215,000 shares.

The Form 4 discloses a non‑cash grant of 150,000 restricted shares to director Ronald M. Sparks on 09/30/2025. Such grants are a common executive/director compensation mechanism tying equity to continued service rather than immediate cash payment.

The grant carries a single vesting date of May 20, 2028 and is explicitly subject to forfeiture if the requisite service period is not completed, which aligns the director's incentive with multi‑year company performance and retention goals.

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider Sparks Ronald M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock	150,000	$0.00	$0.00

Holdings After Transaction: Common stock — 215,000 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction was reported for PAVmed (PAVM) on this Form 4?

The report discloses a grant of 150,000 restricted common shares to director Ronald M. Sparks on 09/30/2025.

When do the restricted shares vest?

The restricted stock has a single vesting date of May 20, 2028.

How many PAVmed shares does the reporting person own after the grant?

Following the transaction the reporting person beneficially owns 215,000 shares.

Was there any cash paid for the restricted shares?

No cash was paid; the transaction price is reported as $0.

Is there any forfeiture condition attached to the grant?

Yes, the restricted stock is subject to forfeiture if the requisite service period is not completed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sparks Ronald M

(Last) (First) (Middle)

360 MADISON AVENUE

25TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	09/30/2025		A		150,000(1)	A	$0(1)	215,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon, by power of attorney	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.